VP-16, vincristine and procarbazine with radiation therapy for treatment of malignant brain tumors
暂无分享，去创建一个
[1] T. Morgan,et al. Synergistic antitumor activity of vincristine and VP-16-213 , 2004, Cancer Chemotherapy and Pharmacology.
[2] M. Mahaley. Neuro-oncology index and review (adult primary brain tumors) , 1991, Journal of neuro-oncology.
[3] Levin Va,et al. Does chemotherapy benefit the patient with a central nervous system glioma , 1987 .
[4] J. Thompson,et al. Prolongation of survival for high-grade malignant gliomas with adjuvant high-dose BCNU and autologous bone marrow transplantation. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] V. Levin,et al. Does chemotherapy benefit the patient with a central nervous system glioma? , 1987, Oncology.
[6] S. Nutik,et al. Phase III comparison of BCNU and the combination of procarbazine, CCNU, and vincristine administered after radiotherapy with hydroxyurea for malignant gliomas. , 1985, Journal of neurosurgery.
[7] M. D’Incalci,et al. Etoposide (VP-16-213) in malignant brain tumors: a phase II study. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] C. Spurr,et al. Lack of potentiation of vincristine‐induced neurotoxicity by VP‐16–213 , 1983, American journal of clinical oncology.
[9] V. Levin,et al. Brain tumor chemotherapy: an evaluation of agents in current use for phase II and III trials. , 1980, Cancer treatment reports.